Key Financial Data Of Group

RaQualia Pharma Inc. - Filing #7272582

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of group
Business results of group
Ordinary profit (loss)
196,726,000 JPY
-361,511,000 JPY
-293,400,000 JPY
-444,848,000 JPY
904,338,000 JPY
701,303,000 JPY
656,248,000 JPY
863,946,000 JPY
-527,654,000 JPY
-550,168,000 JPY
Profit (loss) attributable to owners of parent
-495,031,000 JPY
-323,662,000 JPY
723,390,000 JPY
755,788,000 JPY
-606,985,000 JPY
Comprehensive income
-657,367,000 JPY
-197,678,000 JPY
693,901,000 JPY
774,899,000 JPY
-610,082,000 JPY
Net assets
5,864,166,000 JPY
5,570,509,000 JPY
6,120,443,000 JPY
5,862,864,000 JPY
5,496,981,000 JPY
5,346,751,000 JPY
4,777,596,000 JPY
4,788,004,000 JPY
4,141,795,000 JPY
4,011,129,000 JPY
Total assets
9,673,112,000 JPY
9,655,482,000 JPY
6,871,972,000 JPY
6,596,413,000 JPY
6,257,653,000 JPY
6,091,419,000 JPY
5,210,715,000 JPY
5,234,197,000 JPY
4,367,594,000 JPY
4,251,235,000 JPY
Net assets per share
267.27
253.83
281.87
269.95
261.65
254.49
227.47
227.97
197.12
190.88
Basic earnings (loss) per share
2.60
-22.87
-14.98
-19.95
34.50
27.83
29.34
36.07
-28.97
-31.26
Diluted earnings per share
2.60
34.47
27.81
29.31
36.04
Equity-to-asset ratio
0.603 xbrli:pure
0.574 xbrli:pure
0.887 xbrli:pure
0.885 xbrli:pure
0.877 xbrli:pure
0.876 xbrli:pure
0.915 xbrli:pure
0.913 xbrli:pure
0.946 xbrli:pure
0.941 xbrli:pure
Rate of return on equity
0.010 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.141 xbrli:pure
0.115 xbrli:pure
0.138 xbrli:pure
0.172 xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
147.69 xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
35.71 xbrli:pure
44.27 xbrli:pure
40.01 xbrli:pure
32.55 xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
180,945,000 JPY
-718,596,000 JPY
1,480,084,000 JPY
366,027,000 JPY
-289,208,000 JPY
Net cash provided by (used in) investing activities
-3,665,610,000 JPY
-135,373,000 JPY
-47,649,000 JPY
-279,251,000 JPY
225,475,000 JPY
Net cash provided by (used in) financing activities
2,982,105,000 JPY
793,450,000 JPY
-29,563,000 JPY
-16,441,000 JPY
-6,961,000 JPY
Cash and cash equivalents
3,141,929,000 JPY
3,664,738,000 JPY
3,679,304,000 JPY
2,240,661,000 JPY
2,061,316,000 JPY
Number of employees
64 xbrli:pure
85 xbrli:pure
67 xbrli:pure
64 xbrli:pure
65 xbrli:pure
62 xbrli:pure
62 xbrli:pure
67 xbrli:pure
64 xbrli:pure
70 xbrli:pure
Average number of temporary employees
9 xbrli:pure
14 xbrli:pure
8 xbrli:pure
8 xbrli:pure
7 xbrli:pure
7 xbrli:pure
6 xbrli:pure
6 xbrli:pure
5 xbrli:pure
5 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.